DxTerity Founder & CEO Bob Terbrueggen to speak at the CEO Healthcare Symposium in New York
This May 1 and May 2, 2018, the Young Jewish Professionals Organization is hosting its annual CEO Healthcare Symposium in New York City, NY, and Bob Terbrueggen, DxTerity Founder & CEO, will be one of the featured speakers.
New and Disruptive Models of Providing Care & Genomics
Bob will speak on the topic, “New and Disruptive Models of Providing Care & Genomics,” and discuss how DxTerity, a Los Angeles-based genomics company, is developing from-home RNA monitoring tests—powered by its DxCollect® Fingerstick Collection kit and DxDirect® Genomics Platform—to improve the management of chronic autoimmune diseases like lupus and multiple sclerosis.
The CEO Healthcare Symposium
The CEO Healthcare Symposium convenes over 200 industry-leading executives, clinicians, entrepreneurs, and investors to explore solutions to the most pressing problems in today’s healthcare marketplace. The event is sponsored by the Young Jewish Professionals Organization, the world’s largest group of leaders, executives, and professionals dedicated to educating, inspiring, and mentoring the next generation of Jewish business leaders.
To learn more about the event, please visit the CEO Healthcare Symposium website.
Details for those attending:
Time: 9:15 to 10:30am in the Yellow Room
Date: May 2, 2018
Topic: New and Disruptive Models of Providing Care
Speaker: Bob Terbrueggen